AroCell apply for listing on Nasdaq

MONCYTE Health has been selected to join a 4-year Horizon funded project as a core industrial partner.

Orion Corporation and Marinus Pharmaceuticals have decided to mutually terminate their European wide marketing and distribution agreement for ganaxolone.

In a new publication in “Vaccines” from Department of Immunology and Microbiology, Centre for translational Medicine & Parasitology at Copenhagen University, Attana’s technology has been applied to determine the interaction kinetics between antibodies from vaccinated mice and the pathogen antigen used for the vaccines. This provides valuable information for creating a vaccine with optimal neutralizing […]

A commercially available blood test has now been trialled in routine healthcare. “The blood test showed about 90% reliability even in primary care. This may have major implications for all those individuals who seek help for memory loss and suspected Alzheimer’s,” say the researchers at Lund University in Sweden behind the study. The current study, […]

Qlucore will receive an EIC Accelerator grant of EUR 2.5 million to accelerate the development of clinical cancer diagnostics solutions for acute myeloid leukemia (AML) as well as bladder cancer. In March the grant was made public and Qlucore is now starting the project and has received the first payment. The project will stretch over […]

The company has announced the successful closure of an oversubscribed bridge financing round. Funding was provided by existing investors, such as Northern Venture CapSek, and new shareholders. The money will be used to support ongoing regulatory efforts and development of the company’s AI-driven support tool, Dermalyser, a clinically validated decision support tool for the diagnosis […]

Elypta has announced that the interim results from the LEVANTIS-0087A study will be presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting in San Diego during the Biomarker-Based Screening session on April 9. The population-based case-control study included 2,054 adults over the age of 18 with no symptoms of cancer from the […]